L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of gram-positive bacteria, and activates the lectin pathway of complement

被引:211
作者
Lynch, NJ
Roscher, S
Hartung, T
Morath, S
Matsushita, M
Maennel, DN
Kuraya, M
Fujita, T
Schwaeble, WJ
机构
[1] Univ Leicester, Dept Infect Immun & Inflammat, Leicester LE1 9HN, Leics, England
[2] Univ Konstanz, D-7750 Constance, Germany
[3] Tokai Univ, Dept Appl Biochem, Hiratsuka, Kanagawa 25912, Japan
[4] Tokai Univ, Inst Glycobiol, Hiratsuka, Kanagawa 25912, Japan
[5] Univ Regensburg, Dept Immunol, D-8400 Regensburg, Germany
[6] Fukushima Med Univ, Dept Biochem, Fukushima, Japan
关键词
D O I
10.4049/jimmunol.172.2.1198
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The lectin pathway of complement is activated when a carbohydrate recognition complex and associated serine proteases binds to the surface of a pathogen. Three recognition subcomponents have been shown to form active initiation complexes: mannan-binding lectin (MBL), L-ficolin, and H-ficolin. The importance of MBL in antimicrobial host defense is well recognized, but the role of the ficolins remains largely undefined. This report shows that L-ficolin specifically binds to lipoteichoic acid (LTA), a cell wall component found in all Gram-positive bacteria. Immobilized LTA from Staphylococcus aureus binds L-ficolin complexes from sera, and these complexes initiate lectin pathway-dependent C4 turnover. C4 activation correlates with serum L-ficolin concentration, but not with serum MBL levels. L-ficolin binding and corresponding levels of C4 turnover were observed on LTA purified from other clinically important bacteria, including Streptococcus pyogenes and Streptococcus agalactiae. None of the LTA. preparations bound MBL, H-ficolin, or the classical pathway recognition molecule, C1q. The Journal of Immunology, 2004, 172: 1198-1202.
引用
收藏
页码:1198 / 1202
页数:5
相关论文
共 29 条
[1]   MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway [J].
Dahl, MR ;
Thiel, S ;
Matsushita, M ;
Fujita, T ;
Willis, AC ;
Christensen, T ;
Vorup-Jensen, T ;
Jensenius, JC .
IMMUNITY, 2001, 15 (01) :127-135
[2]  
DODDS AW, 1993, METHOD ENZYMOL, V223, P46
[3]   LIPOTEICHOIC ACID OF BIFIDOBACTERIUM-BIFIDUM SUBSPECIES PENNSYLVANICUM DSM 20239 - A LIPOGLYCAN WITH MONOGLYCEROPHOSPHATE SIDE-CHAINS [J].
FISCHER, W .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1987, 165 (03) :639-646
[4]   STUDIES ON THE CARBOHYDRATE-BINDING CHARACTERISTICS OF HUMAN PULMONARY SURFACTANT-ASSOCIATED PROTEIN-A AND COMPARISON WITH 2 OTHER COLLECTINS - MANNAN-BINDING PROTEIN AND CONGLUTININ [J].
HAURUM, JS ;
THIEL, S ;
HAAGSMAN, HP ;
LAURSEN, SB ;
LARSEN, B ;
JENSENIUS, JC .
BIOCHEMICAL JOURNAL, 1993, 293 :873-878
[5]  
IKEDA K, 1987, J BIOL CHEM, V262, P7451
[6]   Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis [J].
Jack, DL ;
Klein, NJ ;
Turner, MW .
IMMUNOLOGICAL REVIEWS, 2001, 180 :86-99
[7]   Human L-ficolin: plasma levels, sugar specificity, and assignment of its lectin activity to the fibrinogen-like (FBG) domain [J].
Le, Y ;
Lee, SH ;
Kon, OL ;
Lu, J .
FEBS LETTERS, 1998, 425 (02) :367-370
[8]   INTERACTION OF PURIFIED LIPOTEICHOIC ACID WITH THE CLASSICAL COMPLEMENT PATHWAY [J].
LOOS, M ;
CLAS, F ;
FISCHER, W .
INFECTION AND IMMUNITY, 1986, 53 (03) :595-599
[9]   A novel human serum lectin with collagen- and fibrinogen-like domains that functions as an opsonin [J].
Matsushita, M ;
Endo, Y ;
Taira, S ;
Sato, Y ;
Fujita, T ;
Ichikawa, N ;
Nakata, M ;
Mizuochi, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (05) :2448-2454
[10]   Cutting edge: Complement-activating complex of ficolin and mannose-binding lectin-associated serine protease [J].
Matsushita, M ;
Endo, Y ;
Fujita, T .
JOURNAL OF IMMUNOLOGY, 2000, 164 (05) :2281-2284